ArticleJournal of epidemiology and global health2026
Application and Presentation of the Edmonton Obesity Staging System in a Lifestyle Medicine Clinic: A Cross-Sectional Study.
Article in Journal of epidemiology and global health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe rising global prevalence of obesity necessitates innovative management strategies. The Edmonton Obesity Staging System (EOSS) offers a more clinically useful approach to assess the attributed obesity risks.
aimsto evaluate the application of EOSS in a primary care-based Lifestyle Medicine Clinic, describe patient characteristics, and analyze factors associated with higher EOSS stages.
methodsA retrospective study was conducted on 960 patients aged fourteen and above who visited the Lifestyle Medicine Clinic at a primary care in 2023. Patients with type 2 diabetes, pregnancy, or age over 65 years were excluded. Data were extracted from electronic medical records. Descriptive statistics and analytical statistics were performed, focusing on demographics, vital signs, lifestyle assessments, obesity-related comorbidities, and management interventions, including EOSS staging.
resultsThe study population was predominantly female (70.6%), with a mean age of 39.17 years. At the presentation to the Lifestyle Medicine Clinic, the prevalence of physical activity was 13.8% and adherence to a low-calorie diet was 15.7%. The most common comorbidities were prediabetes (70.6%) and dyslipidemia (61.8%). EOSS classification placed 23.6% of patients in stage 0, 58.8% in stage 1, and 17.6% in stage 2, with none in stages 3 or 4. Males and adults aged 40 years and above had significantly higher EOSS stages, p < 0.001 for each. Anthropometric measurements, blood pressure, and HbA1c were significantly higher in patients with higher EOSS stage. The engagement rates in nutrition and health education clinics were 90.6% and 59.2% respectively, with 36.8% required pharmacological intervention for weight loss.
conclusionIncorporating EOSS into primary care shows a feasible risk stratification in managing obesity. Further researches are needed to determine the long-term applicability of EOSS and its effect on obesity management in primary care settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.